Length of Time to Clinical Improvement After Orthopedic Oncology Surgery in Patients With Metastatic Cancer: A Multi-Institution Patient-Reported Outcome Study

被引:0
|
作者
Groundland, John [1 ]
Tokson, Jacqueline Hart [1 ]
Hakim, Anne [1 ]
Cizik, Amy [1 ]
Blank, Alan [2 ]
Lerman, Daniel [3 ]
Jones, Kevin [1 ]
Randall, R. Lor [4 ]
机构
[1] Univ Utah, Dept Orthoped Surg, Salt Lake City, UT 84112 USA
[2] Rush Univ, Dept Orthoped Surg, Chicago, IL USA
[3] Colorado Limb Consultants, Dept Orthoped Surg, Denver, CO USA
[4] Univ Calif Davis, Dept Orthoped Surg, Davis, CA USA
关键词
metastatic bone lesion; orthopedic oncology; pathologic fracture; patient-reported outcome; PHYSICAL FUNCTION; ITEM BANK; LONG BONES; PROMIS; VALIDITY; DISEASE; PAIN; SYSTEM; TOOLS;
D O I
10.1002/jso.27932
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundCurrently, there is a paucity of data that describes the length of time required to realize improvement in pain and function following surgery for patients with metastatic cancer to bone.MethodsOne hundred patients with impending or completed pathologic fractures due to metastatic cancer to bone were enrolled in this prospective cohort study. Outcomes were measured with a Computer Adaptive Test of Patient Reported Outcomes for Pain Interference and Physical Function domains, to determine the time required to achieve a Minimal Clinically Important Difference (MCID) in the tested domains.ResultsEighty-one patients were included in the analysis. Thirty-two patients (39.5%) survived and completed the follow-up to 1 year, while 23 (28.4%) died before the end of the data collection. Fifty-one patients (63.0%) achieved at least a 5-point improvement in Physical Function and 59 (72.8%) achieved at least a 5-point improvement in Pain Interference. The time to achieve the MCID was 6 weeks for the Physical Function and 4 weeks for the Pain Interference domain.ConclusionThe majority of patients with impending or completed pathologic fractures due to metastatic cancer see clinically important improvements in pain and function after surgery in an average of 4 and 6 weeks, respectively.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Longitudinal study on the impact of patient-reported fatigue on survival in metastatic cancer patients treated with chemotherapy
    Duong, K.
    Fabre, E.
    Scotte, F.
    Medioni, J.
    Rance, B.
    Bouchouicha, A.
    Oudard, S.
    Elaidi, R.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S232 - S232
  • [42] Are Patient-reported Outcomes Correlated With Clinical Outcomes After Surgery?: A Population-based Study
    Waljee, Jennifer F.
    Ghaferi, Amir
    Cassidy, Ruth
    Varban, Oliver
    Finks, Jonathan
    Chung, Kevin C.
    Carlozzi, Noelle E.
    Dimick, Justin B.
    ANNALS OF SURGERY, 2016, 264 (04) : 682 - 689
  • [43] A Novel Digital Patient-Reported Outcome Platform (Noona) for Clinical Use in Patients With Cancer: Pilot Study Assessing Suitability
    Peltola, Maria Kristiina
    Poikonen-Saksela, Paula
    Mattson, Johanna
    Parkkari, Timo
    JMIR FORMATIVE RESEARCH, 2021, 5 (05)
  • [44] Electronic Patient-Reported Outcome Data Collection Systems in Oncology Clinical Trials: A Survey of Clinical Research Professionals (an Alliance Study)
    Cho, Youmin
    Smith, Ellen M. Lavoie
    Zahrieh, David
    Chow, Selina L.
    Williams, David A.
    Saint Arnault, Denise
    Jiang, Yun
    JCO CLINICAL CANCER INFORMATICS, 2023, 7
  • [45] The effect of Recall Period on the patient-reported cough for patients discharged after lung cancer surgery
    Su, Xueyao
    Gong, Ruoyan
    Xu, Wei
    Shi, Qiuling
    QUALITY OF LIFE RESEARCH, 2022, 31 : S136 - S136
  • [46] A Qualitative Study Exploring the Regional Feasibility of Patient-Reported Outcome Measures (PROMs) Data Collection for Orthopedic Trauma Patients
    Moran, Mary E.
    Canova, Tyler J.
    Hicks, Caleb J.
    Blecker, Nathan R.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [47] Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy
    Naruto Taira
    Yuichiro Kikawa
    Takayuki Iwamoto
    Yuichiro Miyoshi
    Kyoko Hara
    Seiji Yoshitomi
    Hajime Hikino
    Hirotoshi Takahashi
    Daisuke Takabatake
    Shinichiro Kubo
    Masahiko Ikeda
    Hiroyoshi Doihara
    Tadahiko Shien
    Hiromi Okuyama
    Yuko Tanabe
    Fumikata Hara
    Kosho Yamanouchi
    Yasuhiro Hagiwara
    Masataka Sawaki
    Breast Cancer, 2024, 31 : 283 - 294
  • [48] Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy
    Taira, Naruto
    Kikawa, Yuichiro
    Iwamoto, Takayuki
    Miyoshi, Yuichiro
    Hara, Kyoko
    Yoshitomi, Seiji
    Hikino, Hajime
    Takahashi, Hirotoshi
    Takabatake, Daisuke
    Kubo, Shinichiro
    Ikeda, Masahiko
    Doihara, Hiroyoshi
    Shien, Tadahiko
    Okuyama, Hiromi
    Tanabe, Yuko
    Hara, Fumikata
    Yamanouchi, Kosho
    Hagiwara, Yasuhiro
    Sawaki, Masataka
    BREAST CANCER, 2024, 31 (02) : 283 - 294
  • [49] BREAST CONSERVING SURGERY EVALUATION IN BREAST CANCER PATIENTS USING A NEW PATIENT-REPORTED OUTCOME MEASURE FOR BREAST SURGERY
    Troche, N.
    Jimeno, J.
    Leon, E.
    Garcia-Cardo, J.
    Paz, L.
    Estevez, J.
    Hernanz, F.
    Rodriguez San Juan, J. C.
    BRITISH JOURNAL OF SURGERY, 2019, 106 : 11 - 11
  • [50] Patient-Reported Outcome and Experience Measures (PROM/PREM) in Patients Undergoing Liver Surgery with Enhanced Recovery after Surgery (ERAS®): An Exploratory Study
    Rappold, Daniela
    Staettner, Stefan
    Noehammer, Elisabeth
    HEALTHCARE, 2024, 12 (06)